![Jim Goff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jim Goff
No más puestos en curso
Historial de carrera de Jim Goff
Antiguos cargos conocidos de Jim Goff.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AVEXIS INC | Contacto de Relaciones con Inversores | 01/01/2015 | - |
Public Communications Contact | 01/01/2015 | - | |
INTERMUNE INC | Contacto de Relaciones con Inversores | - | - |
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Investor Relations Contact | 2 |
Public Communications Contact | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
InterMune, Inc.
![]() InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Novartis Gene Therapies, Inc.
![]() Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Jim Goff
- Experiencia